06th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200038293 | PRESSURE-REGULATING FLUID TRANSFER SYSTEMS AND METHODS | 2020-02-06 |
20200038294 | TAMPERPROOF ORAL DOSAGE FORM | 2020-02-06 |
20200038295 | COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION WITH REFILLABLE MEDICATION DISPENSING DEVICES AND ASSOCIATED SYSTEMS AND METHODS | 2020-02-06 |
20200038296 | O/W EMULSION COMPRISING A C16-C30 FATTY ALCOHOL, AN ANIONIC SURFACTANT, AN OIL, A WAX AND A HYDROPHILIC SOLVENT | 2020-02-06 |
20200038297 | METHOD FOR PRODUCING CAPSULES COMPRISING AT LEAST ONE VOLATILE COMPOUND, AND RESULTING CAPSULES | 2020-02-06 |
20200038298 | Method Of Protecting Teeth Against Erosion | 2020-02-06 |
20200038299 | METHODS AND KITS FOR COLORING HAIR | 2020-02-06 |
20200038300 | ORAL CARE FORMULATION SYSTEM PROVIDING AMORPHOUS CALCIUM PHOSPHATE | 2020-02-06 |
20200038301 | COSMETIC COMPOSITIONS | 2020-02-06 |
20200038302 | WATER-IN-OIL TYPE EMULSIFICATION COSMETIC | 2020-02-06 |
20200038303 | EXPRESS HAIR COLORING USING HEAT | 2020-02-06 |
20200038304 | MONOSUBSTITUTED UREA DERIVATIVES AS A SELF-TANNING SUBSTANCE | 2020-02-06 |
20200038305 | Sunscreen or Sunblock Composition | 2020-02-06 |
20200038306 | BARBITURIC ACID DERIVATIVES AS SELF-TANNING SUBSTANCES | 2020-02-06 |
20200038307 | FAST DRYING NAIL POLISH TOPCOAT | 2020-02-06 |
20200038308 | WRINKLE REDUCING COMPOSITIONS AND METHODS | 2020-02-06 |
20200038309 | COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | 2020-02-06 |
20200038310 | COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | 2020-02-06 |
20200038311 | MIXTURE OF SUBSTANCES FOR STYLING AGENT | 2020-02-06 |
20200038312 | COSMETIC COMPOSITION OR EXTERNAL COMPOSITION, AND COSMETIC RAW MATERIAL COMPOSITION | 2020-02-06 |
20200038313 | TOPICAL SKIN COMPOSITIONS FOR TREATING WRINKLES | 2020-02-06 |
20200038314 | PROCESS FOR PREVENTING OR SLOWING THE APPEARANCE OF UNATTRACTIVE SIGNS, GENERATED BY POLLUTANTS PRESENT IN THE ATMOSPHERE, ON THE SKIN, THE SCALP, THE HAIR OR THE MUCOUS MEMBRANES | 2020-02-06 |
20200038315 | Colloidal Silver Combined with Plant Extracts for Use in Treating Wounds and Other Skin Conditions | 2020-02-06 |
20200038316 | A DETERGENT PRODUCT FOR COSMETIC USE | 2020-02-06 |
20200038318 | ORAL MEDICATION FORMULATIONS | 2020-02-06 |
20200038319 | ANTIOXIDANT INFUSED GUM FOR IMPROVING ORAL HEALTH | 2020-02-06 |
20200038320 | MULTIMODAL PARTICULATE FORMULATIONS | 2020-02-06 |
20200038321 | METHODS AND PRODUCTS FOR REDUCING ADHESIONS | 2020-02-06 |
20200038322 | COLCHICINE DRUG-TO-DRUG INTERACTIONS | 2020-02-06 |
20200038323 | OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME | 2020-02-06 |
20200038324 | WAX FOAMABLE VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2020-02-06 |
20200038325 | LIPOSOMAL COMPOSITIONS AND METHODS OF USE | 2020-02-06 |
20200038326 | PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE | 2020-02-06 |
20200038327 | NANOPARTICLES FOR DELIVERY OF CHEMOPREVENTIVE AGENTS | 2020-02-06 |
20200038328 | TUNING OF RELEASE KINETICS IN HYDROGELS | 2020-02-06 |
20200038331 | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH | 2020-02-06 |
20200038332 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE | 2020-02-06 |
20200038333 | GRANULATED COMPOSITE, RAPID RELEASE TABLET AND METHOD FOR PRODUCING SAME | 2020-02-06 |
20200038334 | COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION | 2020-02-06 |
20200038335 | GELATIN PRODUCT COMPRISING A CORE COMPONENT AND METHOD FOR PRODUCING SAME | 2020-02-06 |
20200038336 | PARTICLES AND COMPOSITIONS COMPRISING THE SAME FOR TRANSFECTION | 2020-02-06 |
20200038337 | DRUG DELIVERY SYSTEM FOR DELIVERY OF ACID SENSITIVITY DRUGS | 2020-02-06 |
20200038338 | LONG TERM DRUG DELIVERY BY TATTOO | 2020-02-06 |
20200038339 | COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING FEMALE MENOPAUSAL SYMPTOMS, CONTAINING, AS ACTIVE INGREDIENT, PINITOL, D-CHIRO-INOSITOL OR ANALOG COMPOUNDS THEREOF | 2020-02-06 |
20200038340 | PHARMACEUTICAL COMPOUND FOR TREATING COLORECTAL CANCER | 2020-02-06 |
20200038341 | METHODS AND COMPOSITIONS FOR TREATING JOINT DISEASE | 2020-02-06 |
20200038342 | FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY | 2020-02-06 |
20200038343 | METHODS FOR TREATING CANCER | 2020-02-06 |
20200038344 | PROLONGED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)PHENOL | 2020-02-06 |
20200038345 | DISULFIRAM AND METAL SALT STAGGERED ORAL DOSING REGIMEN AND STAGGERED-RELEASE ORAL UNIT DOSAGE FORMS | 2020-02-06 |
20200038347 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING INFLAMMATORY DISEASE, AUTOIMMUNE DISEASE, OR COMBINATION THEREOF, AND METHOD FOR USING SAME | 2020-02-06 |
20200038348 | METHODS AND MATERIALS FOR REDUCING SCAR FORMATION DURING WOUND HEALING | 2020-02-06 |
20200038349 | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF PENETRATING HEAD INJURY | 2020-02-06 |
20200038350 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | 2020-02-06 |
20200038351 | BUTYRATE SALTS FOR USE IN INFLAMMATORY DISEASES | 2020-02-06 |
20200038352 | CO-CRYSTALS OF NURR1-LBD IN COMPLEX WITH A CYCLOPENTENONE PROSTAGLANDIN AND MODULATORS OF NURR1 | 2020-02-06 |
20200038353 | INTRAVENOUS BACLOFEN FORMULATIONS AND TREATMENT METHODS | 2020-02-06 |
20200038354 | Diagnostic Assay and Treatment for Preeclampsia | 2020-02-06 |
20200038355 | ANTIOXIDANTS FOR USE IN OPHTHALMIC SURGERY | 2020-02-06 |
20200038356 | SPECIALIZED PRO-RESOLVING LIPID MEDIATORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND/OR AUTOIMMUNE DISEASES | 2020-02-06 |
20200038357 | USE OF IDHP IN PREPARATION OF DRUG OR HEALTH PRODUCT FOR PREVENTION AND TREATMENT OF CORONARY ATHEROSCLEROSIS DISEASE | 2020-02-06 |
20200038358 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT AT RISK FOR CARDIOVASCULAR DISEASE | 2020-02-06 |
20200038359 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT AT RISK FOR CARDIOVASCULAR DISEASE | 2020-02-06 |
20200038360 | INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR | 2020-02-06 |
20200038361 | BISMUTH-THIOL COMPOSITIONS AND METHODS FOR TREATING WOUNDS | 2020-02-06 |
20200038362 | DOCETAXEL ALBUMIN NANOPARTICLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | 2020-02-06 |
20200038363 | COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL AND MENTAL DISORDERS, CONTAINING SYRINGARESINOL | 2020-02-06 |
20200038364 | PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE | 2020-02-06 |
20200038365 | A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy | 2020-02-06 |
20200038366 | COMPOSITIONS AND METHODS RELATED TO CANNABINOIDS, TERPENOIDS AND ESSENTIAL OILS | 2020-02-06 |
20200038367 | COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES | 2020-02-06 |
20200038368 | METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELTED DISEASES USING SGLT-2 INHIBITORS | 2020-02-06 |
20200038369 | RESCUE TREATMENT OF POST OPERATIVE NAUSEA AND VOMITING | 2020-02-06 |
20200038370 | ANTIPARASITIC ISOXAZOLINE COMPOUNDS, LONG-ACTING INJECTABLE FORMULATIONS COMPRISING THEM, METHODS AND USES THEREOF | 2020-02-06 |
20200038371 | COMPOUND HAVING ANTICANCER ACTIVITY AND PREPARATION METHOD AND APPLICATION | 2020-02-06 |
20200038372 | SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS | 2020-02-06 |
20200038373 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | 2020-02-06 |
20200038374 | [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS | 2020-02-06 |
20200038375 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | 2020-02-06 |
20200038376 | LIQUID ORAL PHARMACEUTICAL DOSAGE FORM COMPRISING AN HISTAMINE H2-RECEPTOR ANTAGONIST AND AN ANTACID | 2020-02-06 |
20200038377 | INHIBITION OF PROTEIN DISULFIDE-ISOMERASE A3 | 2020-02-06 |
20200038378 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | 2020-02-06 |
20200038379 | PHARMACEUTICAL COMPOSITION | 2020-02-06 |
20200038380 | NEW USE OF AMLEXANOX | 2020-02-06 |
20200038381 | METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH AMD3100 AND TACROLIMUS | 2020-02-06 |
20200038382 | METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING IBUDILAST | 2020-02-06 |
20200038383 | IMMEDIATE-RELEASE ABUSE DETERRENT COMPOSITIONS OR MEDICAMENTS FOR TREATING PAIN, ADD, ADHD AND OTHER SYNDROMES OR DISORDERS | 2020-02-06 |
20200038384 | DIHYDROTETRABENAZINE FOR THE TREATMENT OF ANXIETY AND PSYCHOSES | 2020-02-06 |
20200038385 | S1P MODULATING AGENTS | 2020-02-06 |
20200038386 | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING PIRFENIDONE IN SUSTAINED-RELEASE TABLET FORM AND ITS APPLICATION IN THE REGRESSION OF HUMAN CHRONIC RENAL FAILURE, BREAST CAPSULAR CONTRACTURE AND HEPATIC FIBROSIS | 2020-02-06 |
20200038387 | METHODS OF ADMINISTERING PIRFENIDONE THERAPY | 2020-02-06 |
20200038388 | METHODS OF INHIBITING VIRUSES USING COMPOSITIONS TARGETING TSG101-UBIQUITIN INTERACTION | 2020-02-06 |
20200038389 | CAPSID INHIBITORS FOR THE TREATMENT OF HIV | 2020-02-06 |
20200038390 | ORAL TABLET FORMULATION OF LENALIDOMIDE | 2020-02-06 |
20200038391 | 1',3'-Disubstituted-4-Phenyl-3,4,5,6-Tetrahydro-2H,1'H-[1,4']Bipyridinyl-2- '-Ones | 2020-02-06 |
20200038392 | TOPICAL COMPOSITIONS AND METHODS OF PREPARATION AND USE | 2020-02-06 |
20200038393 | APOMORPHINE PLUS BUSPIRONE COMBINATION FOR MEMORY REVIVAL | 2020-02-06 |
20200038394 | PHARMACEUTICAL SALT OF ANTITUMOR HETEROCYCLIC IMIDAZOLE COMPOUND | 2020-02-06 |
20200038395 | METHOD OF REDUCING NEUTROPENIA | 2020-02-06 |
20200038396 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | 2020-02-06 |